Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter M. Hecht currently holds 377,385 shares of Cyclerion Therapeutics, Inc. (CYCN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter M. Hecht has been a net seller of CYCN stock. They have purchased $5.7M and sold $10.1M worth of shares.
Peter M. Hecht's most recent insider trade was on Jan 1, 2024, when they sold 15,000 shares at $0.00 per share.
Peter M. Hecht serves as Executive at Cyclerion Therapeutics, Inc. (CYCN). They have executed 83 insider transactions totaling $15.8M over their tenure at the company.
Peter M. Hecht holds the position of Executive at Cyclerion Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Peter M. Hecht has shown a selling trading pattern, with $5.7M in total purchases and $10.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter M. Hecht was on Jun 3, 2021, when they purchased $2.7M worth of CYCN shares. This transaction involved 823,170 shares at $3.28 per share.
Peter M. Hecht currently owns 377,385 shares of Cyclerion Therapeutics, Inc. (CYCN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter M. Hecht's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter M. Hecht has 83 Form 4 filings on record as an insider at Cyclerion Therapeutics, Inc..
Set alerts for Peter M. Hecht and 40,000+ other insiders.